Use of low osmolar contrast for gastrointestinal studies in low-birth-weight infants.
Metrizamide is a safe, water-soluble contrast medium suitable for bedside gastrointestinal studies in low-birth-weight infants. We describe our experience with 26 patients and 34 examinations. We present illustrative cases and indicate the clinical applications. Similar results are anticipated when less expensive nonionic contrast agents are approved by the Food and Drug Administration for pediatric use.
D004064:Digestive System / Q000000981:diagnostic imaging*; D004341:Drug Evaluation; D005260:Female; D005767:Gastrointestinal Diseases / Q000000981:diagnostic imaging; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D008793:Metrizamide; D009994:Osmolar Concentration; D011859:Radiography
D008793:Metrizamide